Patient and Stakeholder Engagement

Premier Insight 252: A Novel Treatment That Worked So Well It Almost Derailed the Study

We were testing an autologous chondrocyte transplantation system to repair damaged knee cartilage. The problem was that patients felt great after treatment, and saw no need to make follow-up visits. But the FDA required us to track results for seven years. The challenge: To keep patients involved for seven long years, especially active young patients who moved away from their original locations.